We performed BCR repertoire sequencing on an early breast cancer cohort comprising ten participants with sequential tumor biopsy samples obtained during neoadjuvant therapy (25 serial samples: n = 10 before therapy, n = 10 after 9 weeks of therapy and n = 5 on completion of therapy). The gene discussed is BCR; the disease is neoplasm.